What is TTRX's current ratio?

TTRX (TTRX) reported current ratio of 2.2× in Q1 2026.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

TTRX TTRX Current ratio

Current ratio at other companies

Regeneron PharmaceuticalsREGN

3.6×-1.4×

Bausch Health CompaniesBHC

1.3×0.0×

Journey Medical CorporationDERM

1.7×+0.4×

PTH

Pelthos Therapeutics Inc.PTHS

2.8×+2.6×

Celldex TherapeuticsCLDX

8.9×-12.7×

Arcutis Biotherapeutics, Inc.ARQT

2.7×-0.9×

Other financials

Income statement

See full

Operating income-$1.2M-224%

Net income-$971.0K-196%

EPS (diluted)-$0.03-200%

Balance sheet

See full

Cash & equivalents$11.2M+613%

Total debt$6.0M—

Total equity$6.1M+647%

Total assets$18.6M—

Cash flow

See full

Operating cash flow-$1.6M-448%

Valuation

See full

Market cap$217.45M-17.7%

Enterprise value$212.24M—

Returns & leverage

See full

Return on equity-118.8%—

Debt / equity1×—

Where this comes from

Calculated from TTRX’s reported figures.

total current assets/total current liabilities=2.2×

Based on the most recent quarter.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TTRX's current ratio?: TTRX (TTRX) reported current ratio of 2.2× in Q1 2026.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.